MINNEAPOLIS and SAN FRANCISCO – Medtronic, Inc. today announced findings from the DISCERN AF trial, which utilized Medtronic’s Reveal® XT insertable cardiac monitor to conduct long-term monitoring to ...

It started with black bears. It was 1999, and University of Minnesota researcher Paul Iaizzo connected with Tim Laske, now vice president of research in Medtronic's cardiac ablation products business.

BRAMPTON, ON-- Medtronic of Canada today announced it has received Health Canada license for the Reveal LINQ Insertable Cardiac Monitor (ICM), the smallest implantable cardiac monitoring device ...

New Offerings Available to Existing Medtronic Care Management Services Customers as well as New Hospital Systems, Health Plans and Employers “With the rapid spread of COVID-19, we know that ...

SonarMed™ Airway Monitoring System Continuously Checks for Endotracheal Tube Obstruction and Position for Neonates and Infants Providing Immediate, Actionable Intelligence for Clinicians DUBLIN, May ...

Patients using Medtronic pacemakers will soon be able to access data from these implanted devices directly from a new smartphone app, VentureBeat reports. Medtronic officially launched the app, dubbed ...

Clinicians have been able to remotely monitor pacemakers for years thanks to a combination of near-field and remote wireless technologies, but until now, patients haven’t been able to access the data ...

Medtronic's Reveal XT subcutaneous cardiac monitor is now commercially available in the U.S. The company introduced Reveal XT in Europe in July of 2007. The device helps physicians diagnose heart ...

ISC23: Late-breaking results from STROKE AF study reinforce importance of long-term continuous cardiac monitoring in ischemic stroke patients DUBLIN and DALLAS, Feb. 8, 2023 /PRNewswire/ -- Medtronic ...

Medtronic is striking a first-of-its-kind agreement with Minnesota's largest health plan in which the device maker will pay back the insurer if patients using a specific Medtronic diabetes device ...